Roch A M, Thomas V, Quash G, Moulinoux J P, Delcros J G
Int J Cancer. 1984 Jun 15;33(6):787-93. doi: 10.1002/ijc.2910330613.
The transglutaminase-mediated incorporation of putrescine into proteins of plasma derived from 44 patients with histologically defined bronchopulmonary cancer was compared with that from an age-matched group of 18 patients hospitalized with non-malignant diseases. Two types of kinetic data were obtained over a range of putrescine concentrations 0.09 mM to 0.6 mM. Whereas the plasma from all the patients of the control group showed linear kinetics, that from only 24 patients of the cancer group showed linear kinetics. The remaining 20 showed kinetics typical of inhibition by excess substrate. PAGE analysis of [14C] putrescine-bound plasma proteins showed around 15 different bands. Among these putrescine-binding proteins, we identified, with the help of corresponding specific antisera, four protease inhibitors: alpha 2-macroglobulin, alpha 1-antitrypsin, alpha 1-antichymotrypsin and antithrombin III.
将44例经组织学确诊的支气管肺癌患者血浆中的蛋白质通过转谷氨酰胺酶介导掺入腐胺的情况,与18例因非恶性疾病住院的年龄匹配患者的血浆进行了比较。在0.09 mM至0.6 mM的腐胺浓度范围内获得了两种动力学数据。对照组所有患者的血浆显示出线性动力学,而癌症组只有24例患者的血浆显示出线性动力学。其余20例显示出典型的底物过量抑制动力学。对[14C]腐胺结合的血浆蛋白进行的PAGE分析显示约有15条不同的条带。在这些腐胺结合蛋白中,我们借助相应的特异性抗血清鉴定出四种蛋白酶抑制剂:α2-巨球蛋白、α1-抗胰蛋白酶、α1-抗糜蛋白酶和抗凝血酶III。